Vicarious Surgical Inc. (RBOT NYSE) stock market data APIs
$6.1871
-0.19(-3.1%)
as of September 17, 2025
Try our APIs with
free plan!
Vicarious Surgical Inc. Financial Data Overview
Price chart is built with
Anychart
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.
Prev. Close
6.1871
Open
5.9983
High
6.4925
Low
5.9983
52 wk Range
5-19
Market Cap
36 785 K
Shares Outstanding
5 298 K
EPS
-2.23
Beta
1.411
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Vicarious Surgical Inc. data using free add-ons & libraries
Get Vicarious Surgical Inc. Fundamental Data
Vicarious Surgical Inc. Fundamental data includes:
- Net Revenue:
- EBITDA: -60 168 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: -0.14
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Vicarious Surgical Inc. News
New
Vicarious Surgical delays robot clinical timeline
Vicarious Surgical has delayed the clinical timeline for its surgical robot, having previously stated it would initiate first-in-human clinical trials by the end of 2025. During a Q2 earnings call on...
Vicarious Surgical delays robot timeline
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Dive Brief: Vicarious Surgical CEO Stephen From, who sta...
Vicarious Surgical Narrows Loss in Q2
Key Points EPS (Non-GAAP) loss of $2.23 per share was narrower than expected, beating analyst estimates by 10.8%. Operating expenses decreased 24%, driven by reductions across research and developmen...
Vicarious Surgical Inc. (NYSE:RBOT) Reports Narrower Q2 2025 Loss Amid Cost Optimization Efforts
Vicarious Surgical Inc. (NYSE:RBOT [https://www.chartmill.com/stock/quote/RBOT/profile]) reported its second-quarter 2025 financial results, revealing a net loss per share of $2.23, which was narrower...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
